The study is the latest product of a long-term collaboration that Rimfrost established with the University of Bergen for the purpose of learning more about the biological effects and mechanisms of action of proteins and lipids derived from Antarctic krill.
An expanding body of research points to the significant benefits of tocotrienols.
Manufacturers have laid the groundwork to succeed in the fast-growing high-flavanol cocoa category, but there is work still to be done to show consumers that high-flavanol products are more than just desserts.
Do calcium supplements really increase cardiovascular risk? Here’s what the latest research says.
NattoPharma (Oslo, Norway) unveiled its latest vitamin K2 innovation yet at this year’s SupplySide West trade show: the industry’s first and only full-spectrum vitamin K2 ingredient that comprehensively provides menaquinones (MK) 6, 7, 8, and 9, all vital to heart health.
Will brands and formulators have to do better than simply offering higher concentrates in order to keep consumer interested in omega-3s supplements?
In two filings submitted to the International Trade Commission, CRN argued that Amarin was “financially motivated” to expand its near monopoly over a subset of omega-3 products; if successful, CRN says, Amarin’s complaint would make it much more difficult and costly for consumers to access those products.
The prospective study, which included 135,335 participants, found that excessive consumption of carbohydrates is a contributing factor to total mortality.
Amarin’s ITC complaint alleges that synthetically produced omega-3 products that are predominantly composed of EPA in either ethyl ester or re-esterified form are not considered “dietary ingredients” under Section 201(ff)(1) of the Federal Food Drug and Cosmetic Act, and thus, are not legal dietary supplements but unapproved new drugs.
The meta-analysis, comprising 14 randomized, controlled trials featuring 71,899 subjects, found that omega-3s EPA and DHA supplementation may reduce the risk of cardiac death by 8%, and that benefits may be even greater for subjects with elevated triglycerides or LDL cholesterol.
New studies on garlic focus on coronary plaque reduction, immune health, liver function, and weight management.
In the study, performed in subjects with type 2 diabetes, Sabinsa’s Curcumin C3 Complex together with its BioPerine bioavailability booster demonstrated, for the first time, a reduction in lipoprotein(a), a “protective armor” of LDL cholesterol.
The claim confirms soybean oil’s ability to reduce the risk of coronary heart disease.
Research shows that even moderate cocoa consumption may benefit heart, brain, and skin health.
ArteroProtect vitaminK2 and octacosanol supplement may lower LDL cholesterol and triglycerides, and raise HDL cholesterol.
Expanding the frontiers of probiotics research to the brain and the heart.
The study evaluated PerfLoad’s ability to improve metabolic homeostasis and physical performance during high-intensity exercises under anaerobic conditions.
The patent-pending supplement is a combination of Kyowa Hakko’s own Setria glutathoine and L-citrulline that research shows effectively sustains nitric oxide levels.
Daily consumption of phytosterols by millions of adults with severe hypercholesterolemia could save the EU €5.3 billion per year in healthcare costs, according to new Frost & Sullivan analysis.
From clinical research to pricing and supply, here’s what you need to know about CoQ10 these days.
GOED discusses how our understanding of omega-3's role in human health has evolved over time.
With the global astaxanthin market projected to reach $1.1 billion by 2020, scientists are doubling down on research in new health areas.
New studies on krill oil, egg phospholipids, and phospholipid-based curcumin
NattoPharma announced that the company’s NattoPharma International Research Network has received a €4 million grant from the European Commission’s research program, Horizon 2020, to study vitamin K2’s role in vascular health.
In a newly published, secondary analysis of the Physicians’ Health Study II, researchers posit that multivitamin supplementation did not help to prevent the risk of cardiovascular disease (CVD) events, even in subjects who were found to have less-nutritious diets.
